NCT06701760 is a Phase 2 clinical trial of Sodium Lactate in Traumatic Brain Injury, sponsored by University of California, Los Angeles.

Who is sponsoring NCT06701760?

NCT06701760 is sponsored by University of California, Los Angeles.

What drugs are being tested in NCT06701760?

Interventions in NCT06701760: Sodium Lactate, placebo.

What condition does NCT06701760 study?

NCT06701760 studies Traumatic Brain Injury.

Is NCT06701760 still recruiting?

NCT06701760 is currently not yet recruiting. Last updated 16 January 2026.

Last reviewed 2026-01-16 · How we verify

NCT06701760

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sodium Lactate in Severe TBI

Not yet recruiting Phase 2 Last updated 16 January 2026

What this trial tests

Phase 2 trial testing Sodium Lactate in Traumatic Brain Injury in 264 participants. Not yet recruiting.

Timeline

10 January 2028

Primary endpoint
30 December 2035

1 July 2038

Quick facts

Lead sponsor	University of California, Los Angeles
Phase	Phase 2
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	264
Start date	10 January 2028
Primary completion	30 December 2035
Estimated completion	1 July 2038

Drugs / interventions tested

Sodium Lactate (SODIUM LACTATE) — full drug profile →
placebo

Conditions studied

Traumatic Brain Injury — all drugs for Traumatic Brain Injury →

Sponsor

University of California, Los Angeles

Who can join

Adults 18 to 80, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a safety phase 2 clinical trial of intravenous infusion of sodium lactate in patients with severe TBI. This study is intended for patients in the acute setting in an intensive care unit at centers that have been selected to participate in this trial. This is a proof of safety study and biomarker response study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sodium Lactate

Trials testing the same drug.

NCT06634069 — Study SOLACE SEPSIS · Phase 2 · recruiting
NCT04488874 — Sodium Lactate and Brain Relaxation (LSD) · Phase 3 · completed
NCT03730909 — The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia · NA · unknown

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07455136 — A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon · recruiting
NCT07404761 — Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments · NA · recruiting
NCT07230002 — Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in N · NA · recruiting

Other University of California, Los Angeles trials

Trials by the same sponsor.

NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
NCT07467018 — Mobile Vehicle-Based Delivery of Lenacapavir PrEP in Los Angeles County · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06701760 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 16 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06701760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing